326 related articles for article (PubMed ID: 17409387)
1. Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha.
Horion J; Gloire G; El Mjiyad N; Quivy V; Vermeulen L; Vanden Berghe W; Haegeman G; Van Lint C; Piette J; Habraken Y
J Biol Chem; 2007 May; 282(21):15383-93. PubMed ID: 17409387
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes.
Wang J; Mahmud SA; Bitterman PB; Huo Y; Slungaard A
J Biol Chem; 2007 Sep; 282(39):28408-28418. PubMed ID: 17675290
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
Adam E; Quivy V; Bex F; Chariot A; Collette Y; Vanhulle C; Schoonbroodt S; Goffin V; Nguyên TL; Gloire G; Carrard G; Friguet B; De Launoit Y; Burny A; Bours V; Piette J; Van Lint C
Mol Cell Biol; 2003 Sep; 23(17):6200-9. PubMed ID: 12917341
[TBL] [Abstract][Full Text] [Related]
4. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
Mukhopadhyay A; Manna SK; Aggarwal BB
J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
Quivy V; Adam E; Collette Y; Demonte D; Chariot A; Vanhulle C; Berkhout B; Castellano R; de Launoit Y; Burny A; Piette J; Bours V; Van Lint C
J Virol; 2002 Nov; 76(21):11091-103. PubMed ID: 12368351
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation.
Rahman I; Gilmour PS; Jimenez LA; MacNee W
Mol Cell Biochem; 2002; 234-235(1-2):239-48. PubMed ID: 12162440
[TBL] [Abstract][Full Text] [Related]
8. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
Chen Lf ; Fischle W; Verdin E; Greene WC
Science; 2001 Aug; 293(5535):1653-7. PubMed ID: 11533489
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment.
Furumai R; Ito A; Ogawa K; Maeda S; Saito A; Nishino N; Horinouchi S; Yoshida M
Cancer Sci; 2011 May; 102(5):1081-7. PubMed ID: 21299717
[TBL] [Abstract][Full Text] [Related]
10. Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors.
Dai Y; Chen S; Wang L; Pei XY; Funk VL; Kramer LB; Dent P; Grant S
J Biol Chem; 2011 Sep; 286(39):34036-50. PubMed ID: 21816815
[TBL] [Abstract][Full Text] [Related]
11. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
Ashburner BP; Westerheide SD; Baldwin AS
Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
[TBL] [Abstract][Full Text] [Related]
12. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression.
Yamamoto Y; Verma UN; Prajapati S; Kwak YT; Gaynor RB
Nature; 2003 Jun; 423(6940):655-9. PubMed ID: 12789342
[TBL] [Abstract][Full Text] [Related]
13. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.
Katsura T; Iwai S; Ota Y; Shimizu H; Ikuta K; Yura Y
Cancer Gene Ther; 2009 Mar; 16(3):237-45. PubMed ID: 18949013
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells.
Armstrong K; Robson CN; Leung HY
Prostate; 2006 Aug; 66(11):1223-34. PubMed ID: 16683270
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression.
Aguilera C; Hoya-Arias R; Haegeman G; Espinosa L; Bigas A
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16537-42. PubMed ID: 15536134
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway.
Sasaki CY; Barberi TJ; Ghosh P; Longo DL
J Biol Chem; 2005 Oct; 280(41):34538-47. PubMed ID: 16105840
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.
Duan J; Friedman J; Nottingham L; Chen Z; Ara G; Van Waes C
Mol Cancer Ther; 2007 Jan; 6(1):37-50. PubMed ID: 17237265
[TBL] [Abstract][Full Text] [Related]
19. [NF-kappaB modulates activation of the BMP-2 gene by trichostatin A].
Li X; Bai XZ
Mol Biol (Mosk); 2008; 42(6):990-6. PubMed ID: 19140318
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription.
Lee KY; Ito K; Hayashi R; Jazrawi EP; Barnes PJ; Adcock IM
J Immunol; 2006 Jan; 176(1):603-15. PubMed ID: 16365456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
